Oropouche Fever Cases in Guyana
In a recent report, the Pan American Health Organization (PAHO) identified Guyana as the only nation in the Caribbean Community (Caricom) with confirmed cases of Oropouche fever. This viral disease has seen a resurgence across the Americas since late 2023.
According to PAHO’s latest update, 12,786 confirmed cases have been reported across 11 countries this year. Out of these, seven nations are experiencing local transmission, while four have imported cases. The Culicoides paraensis midge is primarily responsible for transmitting this virus.
From January 1 to July 27, Brazil reported the most cases, totaling 11,888, followed by Panama with 501, Peru with 330, Cuba with 28, Colombia with 26, five cases in Venezuela, and one case in Guyana. Additionally, PAHO noted imported cases in Uruguay, Chile, Canada, and the United States. In 2024, the region saw a total of 16,239 cases across 11 countries and one territory, which included four fatalities.
Symptoms of Oropouche fever typically include high fever, severe headaches, and muscle and joint pain. Most patients recover in two to three weeks; however, around 60% may experience relapses. In rare instances, the disease can result in meningitis or encephalitis, and there are particular concerns for pregnant women regarding fetal risks.
Factors such as climate change, deforestation, and urbanization are contributing to the virus’s spread into non-endemic regions, increasing the population of the midge. PAHO emphasizes the need for enhanced surveillance and vector control measures, as there is currently no vaccine or specific antiviral treatment available.
PAHO advises that countries should tailor their actions based on local epidemiological situations to detect the virus’s spread and monitor areas with local transmission effectively. There is also a push to clear midge breeding sites and promote sustainable agricultural practices. Preventive measures, including the use of bed nets, protective clothing, and insect repellents—especially for pregnant women and rural workers—are strongly encouraged.
Strengthening early clinical diagnosis, particularly distinguishing between Oropouche fever and dengue, is also crucial. Treatments should focus on alleviating symptoms like pain and fever, maintaining hydration, and managing vomiting while keeping an eye on potential neurological complications in pregnant women.
Lastly, PAHO highlights the importance of national and regional collaboration in monitoring and controlling the virus spread. The organization provides technical guidance on diagnosis, clinical management, and vector control, urging countries to report unusual cases, including deaths or vertical transmission.
The Oropouche virus was first identified in 1955 in a worker from a village called Vega de Oropouche, located near the Oropouche River in Trinidad and Tobago, and it remains endemic to the Amazon basin.
